Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on October 27, 2022, to announce its financial results for the third quarter ended September 30, 2022. The report primarily directs investors to a press release (Exhibit 99.1) for detailed financial performance, including both GAAP and non-GAAP measures. Investors should review this press release for specific figures regarding revenue, earnings, and other key financial metrics. The company emphasizes that non-GAAP financial information is provided as a supplemental measure to aid investor understanding and is used internally for operational and planning purposes. A reconciliation between GAAP and non-GAAP figures is available within the press release. While this filing itself doesn't contain the detailed financial tables, it formally notifies the market of the results and directs stakeholders to the complete unaudited financial information.
Key Highlights
- 1Gilead Sciences (GILD) announced its Q3 2022 financial results on October 27, 2022, via an 8-K filing.
- 2The 8-K filing primarily serves to incorporate by reference a press release (Exhibit 99.1) containing the detailed financial results.
- 3Investors are directed to the press release for specific financial performance data for the quarter ended September 30, 2022.
- 4Gilead presented financial information on both a GAAP and a non-GAAP basis.
- 5The company believes non-GAAP measures provide useful insights for investors and are used internally for management purposes.
- 6A reconciliation between GAAP and non-GAAP financial information is provided within the press release.
- 7The information provided in this 8-K filing is not considered 'filed' for certain SEC purposes and does not automatically incorporate by reference into other filings.